Cargando…

Maintaining Low Prevalence of Schistosoma mansoni: Modeling the Effect of Less Frequent Treatment

BACKGROUND: The World Health Organization previously set goals of controlling morbidity due to schistosomiasis by 2020 and attaining elimination as a public health problem (EPHP) by 2025 (now adjusted to 2030 in the new neglected tropical diseases roadmap). As these milestones are reached, it is imp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ayabina, Diepreye, Kura, Klodeta, Toor, Jaspreet, Graham, Matt, Anderson, Roy M, Hollingsworth, T Deirdre
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Supplement Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8201569/ https://www.ncbi.nlm.nih.gov/pubmed/33909064 http://dx.doi.org/10.1093/cid/ciab246

Ejemplares similares

Determining the optimal strategies to achieve elimination of transmission for Schistosoma mansoni
por: Kura, Klodeta, et al.
Publicado: (2022)

Disruptions to schistosomiasis programmes due to COVID-19: an analysis of potential impact and mitigation strategies
por: Kura, Klodeta, et al.
Publicado: (2021)

Policy implications of the potential use of a novel vaccine to prevent infection with Schistosoma mansoni with or without mass drug administration
por: Kura, Klodeta, et al.
Publicado: (2020)

Modelling the impact of a Schistosoma mansoni vaccine and mass drug administration to achieve morbidity control and transmission elimination
por: Kura, Klodeta, et al.
Publicado: (2019)

Achieving Elimination as a Public Health Problem for Schistosoma mansoni and S. haematobium: When Is Community-Wide Treatment Required?
por: Toor, Jaspreet, et al.
Publicado: (2020)

Gender-related differences in prevalence, intensity and associated risk factors of Schistosoma infections in Africa: A systematic review and meta-analysis
por: Ayabina, Diepreye Victoria, et al.
Publicado: (2021)

The impact of mass drug administration on Schistosoma haematobium infection: what is required to achieve morbidity control and elimination?
por: Kura, Klodeta, et al.
Publicado: (2020)

SCHISTOX: An individual based model for the epidemiology and control of schistosomiasis
por: Graham, Matthew, et al.
Publicado: (2021)

Determining post-treatment surveillance criteria for predicting the elimination of Schistosoma mansoni transmission
por: Toor, Jaspreet, et al.
Publicado: (2019)

The design of schistosomiasis monitoring and evaluation programmes: The importance of collecting adult data to inform treatment strategies for Schistosoma mansoni
por: Toor, Jaspreet, et al.
Publicado: (2018)

Dynamics of SARS-CoV-2 with waning immunity in the UK population
por: Crellen, Thomas, et al.
Publicado: (2021)

Economic Evaluations of Mass Drug Administration: The Importance of Economies of Scale and Scope
por: Turner, Hugo C, et al.
Publicado: (2018)

When, Who, and How to Sample: Designing Practical Surveillance for 7 Neglected Tropical Diseases as We Approach Elimination
por: Toor, Jaspreet, et al.
Publicado: (2020)

Pooled Testing for Effective Estimation of the Prevalence of Schistosoma mansoni
por: Mitchell, Shira, et al.
Publicado: (2012)

Distinct Schistosoma mansoni-Specific Immunoglobulin Subclasses Are Induced by Different Schistosoma mansoni Stages—A Tool to Decipher Schistosoma mansoni Infection Stages
por: Arndts, Kathrin, et al.
Publicado: (2021)

Praziquantel Treatment of Schistosoma mansoni Infected Mice Renders Them Less Susceptible to Reinfection
por: Nono, Justin Komguep, et al.
Publicado: (2021)

Frequent Travelers and Rate of Spread of Epidemics
por: Hollingsworth, T. Déirdre, et al.
Publicado: (2007)

Understanding the relationship between egg- and antigen-based diagnostics of Schistosoma mansoni infection pre- and post-treatment in Uganda
por: Prada, Joaquín M., et al.
Publicado: (2018)

The cercarial glycocalyx of Schistosoma mansoni
Publicado: (1985)

CARBOHYDRATE METABOLISM OF SCHISTOSOMA MANSONI
por: Bueding, Ernest
Publicado: (1950)

Imatinib activity on Schistosoma mansoni
por: Katz, Naftale, et al.
Publicado: (2013)

Chlorination of Schistosoma mansoni cercariae
por: Braun, Laura, et al.
Publicado: (2020)

Development and evaluation of a Markov model to predict changes in schistosomiasis prevalence in response to praziquantel treatment: a case study of Schistosoma mansoni in Uganda and Mali
por: Deol, Arminder, et al.
Publicado: (2016)

Investigating the Effectiveness of Current and Modified World Health Organization Guidelines for the Control of Soil-Transmitted Helminth Infections
por: Farrell, Sam H, et al.
Publicado: (2018)

Are We on Our Way to Achieving the 2020 Goals for Schistosomiasis Morbidity Control Using Current World Health Organization Guidelines?
por: Toor, Jaspreet, et al.
Publicado: (2018)

Identification of Schistosoma mansoni microRNAs
por: Simões, Mariana C, et al.
Publicado: (2011)

The genome of the blood fluke Schistosoma mansoni
por: Berriman, Matthew, et al.
Publicado: (2009)

Characterization of the Phytochelatin Synthase of Schistosoma mansoni
por: Ray, Debalina, et al.
Publicado: (2011)

Acute paraplegia caused by Schistosoma mansoni
por: Al-Mendalawi, Mahmood D.
Publicado: (2014)

Proteomic Analysis of the Schistosoma mansoni Miracidium
por: Wang, Tianfang, et al.
Publicado: (2016)

Finding of an unusual ova - Schistosoma mansoni
por: Shanmugam, Dhivyalakshmi, et al.
Publicado: (2015)

Schistosoma mansoni Infection Is Impacted by Malnutrition
por: Maciel, Poliane Silva, et al.
Publicado: (2021)

Does Schistosoma Mansoni Facilitate Carcinogenesis?
por: von Bülow, Verena, et al.
Publicado: (2021)

Prevalence of Schistosoma mansoni–Salmonella coinfection among patients in southern Ethiopia
por: Marege, A., et al.
Publicado: (2021)

Prevalence of Schistosoma mansoni infection among fishermen in Busega district, Tanzania
por: Mang’ara, Revocatus J. L., et al.
Publicado: (2022)

SchistoDB: a Schistosoma mansoni genome resource
por: Zerlotini, Adhemar, et al.
Publicado: (2009)

The observed relationship between the degree of parasite aggregation and the prevalence of infection within human host populations for soil-transmitted helminth and schistosome infections
por: Kura, Klodeta, et al.
Publicado: (2022)

Counting Down the 2020 Goals for 9 Neglected Tropical Diseases: What Have We Learned From Quantitative Analysis and Transmission Modeling?
por: Hollingsworth, T Déirdre
Publicado: (2018)

Engagement and adherence trade-offs for SARS-CoV-2 contact tracing
por: Lucas, Tim C. D., et al.
Publicado: (2021)

What Can Modeling Tell Us About Sustainable End Points for Neglected Tropical Diseases?
por: Minter, Amanda, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0djim1chfrlu51qrvb51irj5a3